Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-12 7:31 pm Sale |
2020-12-31 | 13G | Chewy, Inc. CHWY |
VIKING GLOBAL INVESTORS LP | 0 0.000% |
-2,896,423 (Position Closed) |
Filing History |
| 2021-02-12 7:29 pm Sale |
2020-12-31 | 13G | aTyr Pharma, Inc. LIFE |
VIKING GLOBAL INVESTORS LP | 0 0.000% |
-816,728 (Position Closed) |
Filing History |
| 2021-02-12 7:27 pm Sale |
2020-12-31 | 13G | Canada Goose Holdings Inc. GOOS |
VIKING GLOBAL INVESTORS LP | 0 0.000% |
-3,033,186 (Position Closed) |
Filing History |
| 2021-02-12 1:09 pm Purchase |
2020-12-31 | 13G | Nuance Communications, Inc. NUAN |
VIKING GLOBAL INVESTORS LP | 16,382,663 5.800% |
2,035,647 (+14.19%) |
Filing History |
| 2020-12-23 8:37 pm Unchanged |
2020-12-14 | 13G | AbCellera Biologics Inc. ABCL |
VIKING GLOBAL INVESTORS LP | 19,283,744 7.200% |
0 (Unchanged) |
Filing History |
| 2020-12-21 5:28 pm Purchase |
2020-12-14 | 13G | AbCellera Biologics Inc. ABCL |
VIKING GLOBAL INVESTORS LP | 19,283,744 7.200% |
19,283,744 (New Position) |
Filing History |
| 2020-12-21 5:27 pm Purchase |
2020-12-15 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
VIKING GLOBAL INVESTORS LP | 3,937,914 14.900% |
3,937,914 (New Position) |
Filing History |
| 2020-10-05 5:04 pm Purchase |
2020-09-25 | 13G | PMV Pharmaceuticals, Inc. PMVP |
VIKING GLOBAL INVESTORS LP | 2,641,840 6.100% |
2,641,840 (New Position) |
Filing History |
| 2020-09-28 5:04 pm Purchase |
2020-09-18 | 13G | Athira Pharma, Inc. ATHA |
VIKING GLOBAL INVESTORS LP | 2,120,653 6.900% |
2,120,653 (New Position) |
Filing History |
| 2020-08-31 4:51 pm Purchase |
2020-08-21 | 13G | Inhibrx Biosciences, Inc. INBX |
VIKING GLOBAL INVESTORS LP | 5,125,647 13.600% |
5,125,647 (New Position) |
Filing History |
| 2020-08-10 08:59 am Purchase |
2020-07-29 | 13G | Nuance Communications, Inc. NUAN |
VIKING GLOBAL INVESTORS LP | 14,347,016 5.100% |
14,347,016 (New Position) |
Filing History |
| 2020-08-10 08:55 am Purchase |
2020-07-29 | 13G | Vertex, Inc. VERX |
VIKING GLOBAL INVESTORS LP | 1,852,269 8.200% |
1,852,269 (New Position) |
Filing History |
| 2020-07-27 4:17 pm Purchase |
2020-07-16 | 13G | GoHealth, Inc. GOCO |
VIKING GLOBAL INVESTORS LP | 303,939 5.400% |
303,939 (New Position) |
Filing History |